CL2021000415A1 - Vesículas derivadas de lactobacillus paracasei y uso de las mismas - Google Patents

Vesículas derivadas de lactobacillus paracasei y uso de las mismas

Info

Publication number
CL2021000415A1
CL2021000415A1 CL2021000415A CL2021000415A CL2021000415A1 CL 2021000415 A1 CL2021000415 A1 CL 2021000415A1 CL 2021000415 A CL2021000415 A CL 2021000415A CL 2021000415 A CL2021000415 A CL 2021000415A CL 2021000415 A1 CL2021000415 A1 CL 2021000415A1
Authority
CL
Chile
Prior art keywords
lactobacillus paracasei
vesicles derived
extracellular vesicle
vesicle derived
derived
Prior art date
Application number
CL2021000415A
Other languages
English (en)
Inventor
Yoon-Keun Kim
Chang Mo Moon
Original Assignee
Md Healthcare Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Md Healthcare Inc filed Critical Md Healthcare Inc
Publication of CL2021000415A1 publication Critical patent/CL2021000415A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a una vesícula extracelular derivada de Lactobacillus paracasei y a un uso de la misma, y más particularmente, a una composición para aliviar, prevenir o tratar una enfermedad inflamatoria y un cáncer, que comprende como un ingrediente activo una vesícula extracelular derivada de Lactobacillus paracasei, que puede inhibir de manera efectiva varias enfermedades inflamatorias, y similares.
CL2021000415A 2018-12-31 2021-02-17 Vesículas derivadas de lactobacillus paracasei y uso de las mismas CL2021000415A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20180174027 2018-12-31
KR1020190048671A KR102098067B1 (ko) 2018-12-31 2019-04-25 락토바실러스 파라카제이 유래 소포 및 이의 용도

Publications (1)

Publication Number Publication Date
CL2021000415A1 true CL2021000415A1 (es) 2021-09-20

Family

ID=70291099

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2021000415A CL2021000415A1 (es) 2018-12-31 2021-02-17 Vesículas derivadas de lactobacillus paracasei y uso de las mismas

Country Status (13)

Country Link
EP (1) EP3912631A4 (es)
JP (2) JP7670334B2 (es)
KR (1) KR102098067B1 (es)
CN (1) CN113260372A (es)
AU (1) AU2019419281B2 (es)
BR (1) BR112021003728A2 (es)
CA (1) CA3112889A1 (es)
CL (1) CL2021000415A1 (es)
MX (1) MX2021002412A (es)
MY (1) MY195500A (es)
PH (1) PH12021550985A1 (es)
SG (1) SG11202104315XA (es)
WO (1) WO2020141685A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118360190A (zh) * 2018-05-09 2024-07-19 Ko生物技术有限公司 副干酪乳杆菌菌株及其用途
KR102257130B1 (ko) * 2020-06-16 2021-05-28 주식회사 엠디헬스케어 락토바실러스 파라카세이 유래 소포를 포함하는 신경질환 또는 정신질환 예방 또는 치료용 조성물
CA3181432A1 (en) 2020-06-16 2021-12-23 Yoon-Keun Kim Composition for preventing or treating neurological or mental disorders comprising vesicles derived from lactobacillus paracasei
WO2022015033A1 (ko) * 2020-07-14 2022-01-20 주식회사 리스큐어바이오사이언시스 페디오코쿠스 이노피나투스 또는 이로부터 유래된 세포밖 소포체를 유효성분으로 포함하는 뇌질환의 치료용 조성물
KR102765097B1 (ko) * 2020-12-24 2025-02-12 동아제약 주식회사 신규한 락토바실러스 파라카제이 균주 및 이의 용도
KR102512516B1 (ko) 2021-04-02 2023-03-22 한국과학기술연구원 옵투시폴린 (obtusifolin), 이의 유도체, 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 퇴행성관절염의 예방 또는 치료용 약제학적 조성물
CN115305211A (zh) * 2021-05-07 2022-11-08 葡萄王生技股份有限公司 益生菌胞外泌体及其用途
WO2022255795A1 (ko) * 2021-06-03 2022-12-08 주식회사 엠디헬스케어 락토바실러스 세균 유래 세포외소포 및 이의 용도
US20240252560A1 (en) * 2021-06-03 2024-08-01 Md Healthcare Inc. Lactobacillus rhamnosus-derived vesicle and uses thereof
KR102833393B1 (ko) * 2021-06-18 2025-07-11 한국생명공학연구원 락티카제이바실러스 속 또는 락토바실러스 속 균주를 유효성분으로 포함하는 암 진단, 예방 또는 치료용 조성물
KR102692989B1 (ko) * 2021-07-23 2024-08-07 (주) 에이투젠 신규한 락토바실러스 파라카제이 atg-e1 균주 또는 이를 포함하는 호흡기 질환의 예방 또는 치료용 조성물
CN114085792B (zh) * 2021-11-17 2023-03-24 哈尔滨医科大学 一种用于防治结肠癌的副干酪乳杆菌及其应用
CN114540227B (zh) * 2022-02-21 2023-06-23 南京医科大学 一种具有抑制肝癌肿瘤生长的副干酪乳杆菌l511及其用途
KR20230136548A (ko) 2022-03-18 2023-09-26 주식회사 엠디헬스케어 수율이 향상된 유산균 유래 세포외소포의 제조방법
CN118956679A (zh) * 2024-08-27 2024-11-15 陕西微泌生物科技有限公司 一种益生菌细胞外囊泡模拟物及其制备方法和应用
CN119842565B (zh) * 2025-03-18 2025-08-22 东北农业大学 一株副干酪乳杆菌及其在抗衰老和抗糖化中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120087902A1 (en) 2009-07-20 2012-04-12 Bracco S.P.A. Therapeutic Use Of Probiotics
KR101109744B1 (ko) * 2009-11-13 2012-03-13 충청북도 (관리부서:충청북도 농업기술원) 균체외 다당을 생성하고 건강기능성 효과를 갖는 신규한 락토바실러스 파라카제이
KR101629525B1 (ko) * 2010-01-11 2016-06-13 이화여자대학교 산학협력단 발효식품에서 유래된 세포밖 소포체를 포함하는 조성물 및 이의 용도
EP2589391B1 (en) * 2010-07-01 2018-11-14 Rosetta Exosome Co., Ltd. Bacterial cell-derived microvesicles for use in a method of treating cancer
KR101427363B1 (ko) * 2011-11-23 2014-08-08 주식회사 쎌바이오텍 항암 약제학적 조성물
CN105307673B (zh) * 2012-04-06 2021-04-02 康奈尔大学 用于稳健的体液及细胞免疫应答的亚单位疫苗递送平台
KR101620815B1 (ko) 2014-05-21 2016-05-13 한국생명공학연구원 해양 진균에서 분리한 페니실리놀라이드 a를 유효성분으로 함유하는 염증성 질환 예방 및 치료용 조성물
KR101644595B1 (ko) * 2014-07-11 2016-08-03 한국식품연구원 락토바실러스 파라카제이(Lactobacillus paracasei)를 유효성분으로 포함하는 Ｔｈ1-매개 면역 질환 또는 Ｔｈ2-매개 면역 질환의 예방, 개선 또는 치료용 조성물
KR20160110232A (ko) * 2015-03-11 2016-09-21 주식회사 엠디헬스케어 유산균 유래 세포밖 소포체를 유효성분으로 포함하는 염증질환의 예방 또는 치료용 조성물
CN104894021B (zh) * 2015-06-03 2018-02-09 宜兰食品工业股份有限公司 一种副干酪乳杆菌及其应用
KR102027029B1 (ko) * 2017-05-25 2019-09-30 (주)엠앤씨생명과학 유산균 함유 천연 리포좀, 그 제조방법 및 이를 포함하는 식품 또는 약학 조성물
KR101984022B1 (ko) 2017-10-31 2019-09-03 한국생산기술연구원 콤팩트하고 단순화한 사류 펌프의 디퓨저 설계 방법, 이에 의하여 설계된 디퓨저 및 이를 구비한 사류 펌프

Also Published As

Publication number Publication date
AU2019419281A1 (en) 2021-03-04
PH12021550985A1 (en) 2021-11-08
KR102098067B1 (ko) 2020-04-07
MY195500A (en) 2023-01-26
BR112021003728A2 (pt) 2021-05-25
EP3912631A1 (en) 2021-11-24
JP7670334B2 (ja) 2025-04-30
JP2022514977A (ja) 2022-02-16
MX2021002412A (es) 2021-04-28
CN113260372A (zh) 2021-08-13
SG11202104315XA (en) 2021-05-28
WO2020141685A1 (ko) 2020-07-09
AU2019419281B2 (en) 2023-11-30
EP3912631A4 (en) 2022-11-30
CA3112889A1 (en) 2020-07-09
JP2023109943A (ja) 2023-08-08

Similar Documents

Publication Publication Date Title
CL2021000415A1 (es) Vesículas derivadas de lactobacillus paracasei y uso de las mismas
MX2019005009A (es) 1,2,4-triazolonas 2,4,5-trisustituidas.
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
MX2018012486A (es) Composiciones para aplicacion topica de compuestos.
MX2015003140A (es) Formulaciones de enzalutamida.
UY36665A (es) Derivados de ciclohexano sustituidos con amidas
UY34605A (es) Derivados de arilalquiloxipirimidina e insecticidas agrohortícolas que comprenden dichos derivados como principios activos, y método de uso de los mismos
UY34750A (es) ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
CO2018001628A2 (es) Composiciones y formulaciones antimicrobianas
MX2018013240A (es) Composiciones antiirritantes sinergisticas de taurina y aloe.
MX2019014772A (es) Formulaciones en gel de bisfosfocinas y usos de estas.
MX2015011991A (es) Combinaciones de alquilamidotiazoles y sustancias aromaticas.
MX2018002416A (es) Derivados de 1,7-diaril-1,6-heptadien-3,5-diona, procedimiento para la preparación y uso de los mismos.
NI201500115A (es) Estra-1,3,5(10), 16-tetraeno-3-carboxamidas para la inhibición de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3)
MY193312A (en) Topical formulation for promoting wound healing
MX2020003762A (es) Composiciones cosmeticas y metodo para tratar la piel.
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
CL2017000845A1 (es) Inhibidores de gingipaina de lisina
MX2019006091A (es) Composicion de champu en seco.
MX391152B (es) Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para preparar y utilizar las mismas.
CO2017002813A2 (es) Derivados estabilizados de adrenomedulina y uso de los mismos
UY34543A (es) Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica.
NI202000042A (es) Polimorfos
BR112018003945A2 (pt) extrato de gardenia para tonalizar a pele
BR112017018618A2 (pt) odorizante de osmanthus